Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 2:44 pm Sale | 2022-12-31 | 13G | HyreCar Inc. HYREQ | Altium Capital Management LLC | 1,688,120 5.600% | -48,795 (-2.81%) | Filing History |
| 2023-02-14 2:35 pm Unchanged | 2022-12-31 | 13G | Sadot Group Inc. SDOT | Altium Capital Management LLC | 288,809 4.990% | 0 (Unchanged) | Filing History |
| 2023-02-14 12:35 pm Sale | 2022-12-31 | 13G | NeuroBo Pharmaceuticals, Inc. NRBO | Altium Capital Management LLC | 0 0.000% | -41,667 (Position Closed) | Filing History |
| 2023-02-14 12:26 pm Unchanged | 2022-12-31 | 13G | Palisade Bio, Inc. PALI | Altium Capital Management LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-12-21 2:12 pm Purchase | 2022-12-15 | 13G | Astria Therapeutics, Inc. ATXS | Altium Capital Management LLC | 1,355,372 5.200% | 1,355,372 (New Position) | Filing History |
| 2022-11-17 5:08 pm Purchase | 2022-11-04 | 13G | NeuroBo Pharmaceuticals, Inc. NRBO | Altium Capital Management LLC | 41,667 7.700% | 41,667 (New Position) | Filing History |
| 2022-11-08 7:44 pm Purchase | 2022-09-02 | 13G | HyreCar Inc. HYREQ | Altium Capital Management LLC | 1,736,915 5.800% | 1,736,915 (New Position) | Filing History |
| 2022-02-14 3:09 pm Sale | 2022-02-02 | 13G | Palisade Bio, Inc. PALI | Altium Capital Management LLC | 4,467 9.990% | -859 (-16.13%) | Filing History |
| 2022-02-14 3:06 pm Purchase | 2021-12-31 | 13G | Quoin Pharmaceuticals, Ltd. QNRX | Altium Capital Management LLC | 1,425 4.990% | 1,013 (+245.30%) | Filing History |
| 2022-02-14 2:37 pm Purchase | 2021-12-31 | 13G | Palisade Bio, Inc. PALI | Altium Capital Management LLC | 5,326 4.990% | 3,558 (+201.25%) | Filing History |
| 2022-02-14 2:30 pm Sale | 2021-12-31 | 13G | Regulus Therapeutics Inc. RGLS | Altium Capital Management LLC | 172,978 2.100% | -150,000 (-46.44%) | Filing History |
| 2022-02-14 10:16 am Unchanged | 2021-12-31 | 13G | urban-gro, Inc. UGRO | Altium Capital Management LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-02-14 09:53 am Unchanged | 2021-12-31 | 13G | Opus Genetics, Inc. IRD | Altium Capital Management LLC | 2,678,883 4.990% | 0 (Unchanged) | Filing History |
| 2022-02-14 09:40 am Sale | 2021-12-31 | 13G | Timber Pharmaceuticals, Inc. TMBR | Altium Capital Management LLC | 117,568 4.990% | -60,000 (-33.79%) | Filing History |
| 2022-02-14 06:16 am Sale | 2021-12-31 | 13G | electroCore, Inc. ECOR | Altium Capital Management LLC | 0 0.000% | -333,333 (Position Closed) | Filing History |
| 2022-02-14 06:11 am Purchase | 2021-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | Altium Capital Management LLC | 17,600 1.200% | 17,600 (New Position) | Filing History |
| 2022-02-14 06:09 am Sale | 2021-12-31 | 13G | INmune Bio, Inc. INMB | Altium Capital Management LLC | 0 0.000% | -909,091 (Position Closed) | Filing History |
| 2022-02-14 06:07 am Unchanged | 2021-12-31 | 13G | BioRestorative Therapies, Inc. BRTX | Altium Capital Management LLC | 200,000 4.990% | 0 (Unchanged) | Filing History |
| 2022-02-14 06:05 am Sale | 2021-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Altium Capital Management LLC | 0 0.000% | -4,500 (Position Closed) | Filing History |
| 2022-02-11 9:13 pm Sale | 2021-12-31 | 13G | Xtant Medical Holdings, Inc. XTNT | Altium Capital Management LLC | 6,497,918 7.200% | -2,165,971 (-25.00%) | Filing History |